Warning: Declaration of Bootstrap_Walker_Nav_Menu::start_lvl(&$output, $depth) should be compatible with Walker_Nav_Menu::start_lvl(&$output, $depth = 0, $args = Array) in /home/moneytree/domains/moneytreepodcast.com/public_html/wp-content/themes/stanleywp/functions/function-extras.php on line 61

Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home/moneytree/domains/moneytreepodcast.com/public_html/wp-content/themes/stanleywp/functions/function-extras.php:61) in /home/moneytree/domains/moneytreepodcast.com/public_html/wp-content/plugins/global-content-blocks/global-content-blocks.php on line 302

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home/moneytree/domains/moneytreepodcast.com/public_html/wp-content/themes/stanleywp/functions/function-extras.php:61) in /home/moneytree/domains/moneytreepodcast.com/public_html/wp-content/plugins/global-content-blocks/global-content-blocks.php on line 302
Biotech Sector Investing with Brad LoncarMoney Tree Investing Podcast

MTI077: Biotech Sector Investing with Brad Loncar

Biotechnology has been the stock market’s best performing sector over the last 4-5 years, according to Brad Loncer, a private investor with a biotech focus.

Cancer immunotherapy caught his attention. It is a treatment that uses your body’s own immune system to help fight cancer. A handful of drugs are already on the market and are revolutionizing treatment of melanoma.

Brad sees biotech as being a profitable part of any investor’s portfolio.  Admittedly, it is volatile so he highly recommends we be diversified. That is why he created the Loncar Cancer Immunotherapy Index (LCINDX) – an equally weighted ETF.

Find out more at Loncarindex.com

Today’s panelists

 

For a quick bio of each of our show participants, head on over to our panelists page.